This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Successfully funded
overfunded
Doctaly
161%
Raised
£807,580
Investors
1134
Target
£500,000
Equity
11.86%
Pre-money valuation
£6,000,000

Doctaly is a health-tech marketplace, bringing on-demand, affordable, face-to-face GP appointments to patients and Uber-style flexibility to NHS doctors. Having completed a successful pilot in London, they are poised to expand their service and are in talks with NHS England and Bupa.

  • Tech platform & pilot funded by £600k from founders & seed investors
  • Received national press coverage – The Mail, Times & front page of I
  • Scalable model will leverage existing NHS GP practices across the UK
  • Backed and advised by technology and medical veterans

Idea

Doctaly is the UK’s first online GP marketplace enabling patients to book a convenient face-to-face consultation with an NHS GP on a private, fee paying basis. We bring the similar dentistry model to General Practice for the benefit of both doctors and patients.

General Practice is widely recognised as being in crisis. An ageing and growing population, lack of funding, and falling GP income has resulted in many doctors leaving the profession. Average patient waiting time to see their registered GP now exceeds two weeks in London, up 35% in one year.

Our model seeks to alleviate the problems on both sides, by providing additional flexibility and income for the doctor, and access, choice and convenience for the patient. Doctors treat Doctaly patients at their existing practice, working around their existing NHS commitments.

There are over 40 GP appointments (NHS & private) every second in the UK. Market research commissioned by us shows that there is sufficient demand to quadruple the size of the private GP market: around 8m appointments per year. We believe the Doctaly model is scalable, with almost 10,000 GP practices in the UK set up to treat private patients immediately.

We launched a pilot in 2016, receiving national press coverage. Our successful pilot proved the business model and with your support, we are now looking to grow the business aggressively throughout the UK.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Doctaly pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered? Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Doctaly has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.